300601 康泰生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产494,91616.79%423,773494949
固定资产4,188,93521.97%3,434,5331,712,9701,796,2041,142,783
在建工程1,478,247-35.21%2,281,4523,463,1562,320,1971,136,280
无形资产452,9704.50%433,455357,979346,042294,365
商誉0--0000
其他非流动资产3,311,0456.25%3,116,1423,077,3482,345,8021,666,461
9,926,1132.44%9,689,3558,611,5026,808,2954,239,938

流动资产
货币资金323,145-72.97%1,195,5821,017,6223,549,514882,693
应收账款2,802,9970.55%2,787,6082,293,3011,460,4711,613,172
存货894,84015.78%772,854727,7991,058,194436,545
其他流动资产498,362-22.13%639,9591,136,1281,272,5112,412,159
4,519,343-16.25%5,396,0045,174,8507,340,6905,344,570

流动负债
短期借款158,600164.14%60,043170,071777,53111,323
应付票据98,3507.72%91,304114,46307,212
应付帐款696,432-11.98%791,177319,670708,196160,149
其他流动负债1,738,909-3.87%1,808,8261,735,6091,132,4071,577,258
2,692,291-2.15%2,751,3512,339,8122,618,1351,755,942
流动资产净值1,827,052-30.92%2,644,6532,835,0384,722,5553,588,627
资产总额减流动负债11,753,165-4.71%12,334,00811,446,54011,530,8507,828,565

非流动负债
长期借款85,000-87.34%671,257404,712417,53667,795
应付债券1,745,4312.61%1,700,9591,610,9681,520,4340
其他非流动负债388,045-7.63%420,107445,521426,144297,334
2,218,476-20.55%2,792,3222,461,2022,364,115365,129

总权益
    实收股本1,116,9170.00%1,116,9171,120,494687,094684,927
    储备项目8,417,756-0.08%8,424,7697,864,8448,479,6426,778,509
股东权益9,534,673-0.07%9,541,6858,985,3389,166,7367,463,436
非控股权益16--0000